![](/img/cover-not-exists.png)
Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study
Link, Hartmut, Illerhaus, G., Martens, U. M., Salar, A., Depenbusch, R., Köhler, A., Engelhardt, M., Mahlmann, S., Zaiss, M., Lammerich, A., Bias, P., Buchner, A.Journal:
Supportive Care in Cancer
DOI:
10.1007/s00520-020-05711-7
Date:
September, 2020
File:
PDF, 607 KB
2020